Skip to content

Expiring federal contract · order under a contract vehicle

75N91023F00003 — The Univeristy Of Texas M.d. Anderson Cancer Center

Department of Health and Human Services · National Institutes of Health

Contract / PIID
75N91023F00003
Incumbent
The Univeristy Of Texas M.d. Anderson Cancer Center
Incumbent UEI
S3GMKS8ELA16
Current end date
March 14, 2027
Potential total value
$1,272,481
Obligated
$1,272,481
NAICS
541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Set-aside
Full & Open
Start date
September 15, 2023
Place of performance
TX
Award type
DELIVERY ORDER

Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.

What the contract covers

TARGETING THE A2B ADENOSINE RECEPTOR FOR IMMUNOPREVENTION OF PANCREATIC CANCER

Likely rebid window (estimate)

  • Sources Sought / RFI: about Mar 2026 – Sep 2026 (6–12 months before the end date)
  • RFP: about Nov 2026 – Jan 2027 (2–4 months before the end date)

Now inside the estimated RFP window.

This is an order under contract vehicle 75N91019D00021. Orders are usually not competed on their own: the next order may be placed under the same vehicle.

Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.

Track this recompete free

  • Change history: no changes recorded since Mindy began tracking this contract.
  • Alerts: get an email when the end date moves or the follow-on is posted.
  • Contacts: the buying office and small-business contacts for this agency.

Other contracts expiring at Department of Health and Human Services (NAICS 541714)